Viewing Study NCT05443334


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-03-03 @ 4:22 AM
Study NCT ID: NCT05443334
Status: COMPLETED
Last Update Posted: 2025-09-24
First Post: 2022-06-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Sponsor: Novo Nordisk A/S
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-07-28
Start Date Type: ACTUAL
Primary Completion Date: 2024-07-04
Primary Completion Date Type: ACTUAL
Completion Date: 2024-07-04
Completion Date Type: ACTUAL
First Submit Date: 2022-06-29
First Submit QC Date: None
Study First Post Date: 2022-07-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-23
Last Update Post Date: 2025-09-24
Last Update Post Date Type: ESTIMATED